Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients

Peter A. Lee, Michael R. Kelly, John D. Wallin

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.

Original languageEnglish (US)
Pages (from-to)2316-2317
Number of pages2
JournalJAMA: The Journal of the American Medical Association
Volume235
Issue number21
DOIs
StatePublished - May 24 1976

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients'. Together they form a unique fingerprint.

Cite this